Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

155940 Press Releases
DateTitleCompany
27 Feb 17 Digestive Enzyme Supplements Market to Reach $1.6 Billion by 2025 - Increasing Incidence of Gastrointestinal Tract Diseases - Research and Markets Research and Markets,
Published by
Business Wire
27 Feb 17 Global Viral Partnering 2010-2017: Deal Trends, Players and Financials - Research and Markets Research and Markets,
Published by
Business Wire
27 Feb 17 Unum Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference Unum Therapeutics,
Published by
Business Wire
27 Feb 17 Global Inflammatory Bowel Disease Partnering Deals and Agreements 2010-2017 - Research and Markets Research and Markets,
Published by
Business Wire
27 Feb 17 Global Crohn's Disease Partnering Deals and Agreements 2010 to 2017 - Research and Markets Research and Markets,
Published by
Business Wire
27 Feb 17 Syros Reports Discovery of Novel Genomics Based Approach to Stratifying Patients with Acute Myeloid Leukemia at Cold Spring Harbor Conference Syros Pharmaceuticals, Inc.,
Published by
Business Wire
27 Feb 17 Acorda to Present at the Cowen and Company 37th Annual Healthcare Conference Acorda Therapeutics, Inc.,
Published by
Business Wire
27 Feb 17 BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0 BTG plc,
Published by
Business Wire
27 Feb 17 TheraVida Announces Publication of Phase 2 Results for THVD-102 in Hyperhidrosis TheraVida, Inc.,
Published by
Business Wire
27 Feb 17 CureDuchenne Ventures Invests in New Gene Editing Company Exonics Therapeutics to Advance CRISPR/Cas9 Therapy for Duchenne Muscular Dystrophy CureDuchenne,
Published by
Business Wire
27 Feb 17 Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO Arrakis Therapeutics,
Published by
Business Wire
27 Feb 17 Aerie Pharmaceuticals to Announce Fourth Quarter and Year End 2016 Financial Results and Host Conference Call on Tuesday, March 7, 2017 Aerie Pharmaceuticals, Inc.,
Published by
Business Wire
27 Feb 17 HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017 Published by
GlobeNewswire
27 Feb 17 Recro Pharma Completes Enrollment in Phase III Safety Study of IV Meloxicam Published by
GlobeNewswire
27 Feb 17 Axsome Therapeutics to Present at the 29th Annual ROTH Conference Published by
GlobeNewswire
27 Feb 17 Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy Published by
GlobeNewswire
27 Feb 17 On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day Published by
GlobeNewswire
27 Feb 17 Antares Pharma Announces FDA Acceptance of New Drug Application for Quickshot® Testosterone Published by
GlobeNewswire
27 Feb 17 Leidos Health Ranked in 2017 Best in KLAS Awards: Professional Services Leidos,
Published by
PR Newswire
27 Feb 17 $8.8 Billion Cardiac Resynchronization Therapy (CRT) Market - Analysis By Product (Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]) - Research and Markets Research and Markets,
Published by
PR Newswire
27 Feb 17 78% Stroke Reduction with Newer No-Touch Beating Heart Bypass Surgery, According to Landmark Study Sydney Heart and Lung Surgeons,
Published by
PR Newswire
27 Feb 17 Nabriva Therapeutics to Present at the Cowen and Company 37th Annual Healthcare Conference Published by
GlobeNewswire
27 Feb 17 BioCryst Reports Positive Interim Results from its APeX-1 Trial Published by
GlobeNewswire
27 Feb 17 $8.8 Billion Cardiac Resynchronization Therapy (CRT) Market - Analysis By Product (Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]) - Research and Markets Research and Markets,
Published by
PR Newswire
27 Feb 17 $8.8 Billion Cardiac Resynchronization Therapy (CRT) Market - Analysis By Product (Cardiac Resynchronization Therapy Pacemakers [CRT-P], Cardiac Resynchronization Therapy Defibrillators [CRT-D]) - Research and Markets Research and Markets,
Published by
PR Newswire
27 Feb 17 Merus to Present at the Cowen & Co. 37th Annual Health Care Conference Merus N.V.,
Published by
GlobeNewswire
27 Feb 17 Orion Group Financial Statement documents 2016 and Corporate Governance Statement published Orion Oyj,
Published by
GlobeNewswire
27 Feb 17 Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences Published by
GlobeNewswire
27 Feb 17 Orion Group Financial Statement documents 2016 and Corporate Governance Statement published Published by
GlobeNewswire
27 Feb 17 OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.